Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway

Although cisplatin (cDDP), is a first-line chemotherapy drug for esophageal cancer, it still has the potential to develop drug resistance and side effects. There is increasing evidence that cordycepin can work synergistically with other chemotherapy drugs. Therefore, we investigated whether combinat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Main Authors: Gao, Ying, Chen, Dan-Lei, Zhou, Mi, Zheng, Zhou-san, He, Mei-Fang, Huang, Sheng, Liao, Xiao-Zhong, Zhang, Jia-Xing
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7567864/
https://ncbi.nlm.nih.gov/pubmed/33067427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03079-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares